Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS.

× No keyword cloud information.

49 in total

Review 1. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors: Berislav V Zlokovic
Journal: Nat Rev Neurosci Date: 2011-11-03 Impact factor: 34.870

2. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors: Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal: J Cereb Blood Flow Metab Date: 2011-11-09 Impact factor: 6.200

3. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

Authors: Donghui Zhu; Yaoming Wang; Itender Singh; Robert D Bell; Rashid Deane; Zhihui Zhong; Abhay Sagare; Ethan A Winkler; Berislav V Zlokovic
Journal: Blood Date: 2010-03-26 Impact factor: 22.113

4. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.

Authors: Hirohide Asai; Seiko Ikezu; Maya E Woodbury; Grant M S Yonemoto; Libin Cui; Tsuneya Ikezu
Journal: Am J Pathol Date: 2014-01-10 Impact factor: 4.307

Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS.

Review 1. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

2. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

3. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

4. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.

Review 5. Cerebrovascular disorders: molecular insights and therapeutic opportunities.

6. Reduction of circulating endothelial cells in peripheral blood of ALS patients.

Review 7. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Review 8. VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration.

9. Current and emerging treatments for amyotrophic lateral sclerosis.

Review 10. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.